Scholarlink

Background <p>Diabetes is considered to be one of the most important metabolic conditions causing left ventricular (LV) dysfunction, one of which is Left ventricular hypertrophy (LVH). Increased left ventricular mass (LVM) and left ventricular mass index (LVMI) are significant predictors of LVH.</p> Aim <p>This study aims to illustrate the significance of using echocardiography to detect left ventricular hypertrophy (as a type of LV dysfunction) in normotensive patients with type 2 diabetes mellitus.</p> Materials and methods <p>The study included 100 participants who were distributed into two groups: group A included normotensive patients with type 2 DM and group B included normotensive non-diabetic patients as a control group.</p> Results <p>LVM values were significantly higher in group A patients compared to group B (187.11&#xa0;±&#xa0;60.83 vs. 119.15&#xa0;±&#xa0;41.87, <i>p&#xa0;&lt;&#xa0;</i>0.001). Also, LVMI values were significantly higher in group A in comparison to group B (96.64&#xa0;±&#xa0;29.84 vs. 63.17&#xa0;±&#xa0;20.38, <i>p&#xa0;&lt;&#xa0;</i>0.001). The proportion of abnormal LVMI was higher in group A than group B (56% vs. 6%, <i>p&#xa0;&lt;&#xa0;</i>0.001). There was a statistically significant positive correlation between LVM and several study parameters including disease duration (<i>r&#xa0;=&#xa0;</i>0.369, <i>p</i>&#xa0;=&#xa0;0.008), FBS (<i>r&#xa0;=&#xa0;</i>0.478, <i>p&#xa0;&lt;&#xa0;</i>0.001), 2HPP (0.400, <i>p&#xa0;</i>=&#xa0;0.004), HA1C (%) (<i>r&#xa0;=&#xa0;</i>0.589, <i>p</i>&#xa0;=&#xa0;0.003), LVEDD (<i>r&#xa0;=&#xa0;</i>0.790, <i>p&#xa0;&lt;&#xa0;</i>0.001), LVESD (<i>r&#xa0;=&#xa0;</i>0.388, <i>p</i>&#xa0;=&#xa0;0.005), SWT (<i>r&#xa0;=&#xa0;</i>0.897, <i>p&#xa0;&lt;&#xa0;</i>0.001), PWT (<i>r&#xa0;=&#xa0;</i>0.808, <i>p&#xa0;&lt;&#xa0;</i>0.001), and LA (<i>r&#xa0;=&#xa0;</i>0.322, <i>p</i>&#xa0;=&#xa0;0.022).</p> Conclusion <p>Left ventricular mass was found to be significantly higher in normotensive type 2 DM patients in comparison to the normotensive non-diabetic control group. LVM is a good marker of LVH among normotensive diabetics and significantly correlates with DM control and duration.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Increased left ventricular mass as a marker of left ventricular hypertrophy in normotensive type 2 DM patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月3日

查看全文
  • Moustafa Kamal Eldin Ibrahim Khalil Saad,
  • Mohamed Saleh Gomaa,
  • Abdelrahman Ahmed Ewais,
  • Maher Abobaker Alamir,
  • Mohamed Shaban Hashem Mahmoud

摘要

Background

Diabetes is considered to be one of the most important metabolic conditions causing left ventricular (LV) dysfunction, one of which is Left ventricular hypertrophy (LVH). Increased left ventricular mass (LVM) and left ventricular mass index (LVMI) are significant predictors of LVH.

Aim

This study aims to illustrate the significance of using echocardiography to detect left ventricular hypertrophy (as a type of LV dysfunction) in normotensive patients with type 2 diabetes mellitus.

Materials and methods

The study included 100 participants who were distributed into two groups: group A included normotensive patients with type 2 DM and group B included normotensive non-diabetic patients as a control group.

Results

LVM values were significantly higher in group A patients compared to group B (187.11 ± 60.83 vs. 119.15 ± 41.87, p < 0.001). Also, LVMI values were significantly higher in group A in comparison to group B (96.64 ± 29.84 vs. 63.17 ± 20.38, p < 0.001). The proportion of abnormal LVMI was higher in group A than group B (56% vs. 6%, p < 0.001). There was a statistically significant positive correlation between LVM and several study parameters including disease duration (r = 0.369, p = 0.008), FBS (r = 0.478, p < 0.001), 2HPP (0.400, p = 0.004), HA1C (%) (r = 0.589, p = 0.003), LVEDD (r = 0.790, p < 0.001), LVESD (r = 0.388, p = 0.005), SWT (r = 0.897, p < 0.001), PWT (r = 0.808, p < 0.001), and LA (r = 0.322, p = 0.022).

Conclusion

Left ventricular mass was found to be significantly higher in normotensive type 2 DM patients in comparison to the normotensive non-diabetic control group. LVM is a good marker of LVH among normotensive diabetics and significantly correlates with DM control and duration.